Technical Report abstract


Nature Neuroscience 10, 923 - 929 (2007)
Published online: 17 June 2007 | doi:10.1038/nn1927

From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors

Peer Wulff1,6,7, Thomas Goetz1,6,7, Elli Leppä2, Anni-Maija Linden2, Massimiliano Renzi3, Jerome D Swinny4, Olga Y Vekovischeva2, Werner Sieghart5, Peter Somogyi4, Esa R Korpi2, Mark Farrant3 & William Wisden1,6


In mammals, identifying the contribution of specific neurons or networks to behavior is a key challenge. Here we describe an approach that facilitates this process by enabling the rapid modulation of synaptic inhibition in defined cell populations. Binding of zolpidem, a systemically active allosteric modulator that enhances the function of the GABAA receptor, requires a phenylalanine residue (Phe77) in the gamma2 subunit. Mice in which this residue is changed to isoleucine are insensitive to zolpidem. By Cre recombinase–induced swapping of the gamma2 subunit (that is, exchanging Ile77 for Phe77), zolpidem sensitivity can be restored to GABAA receptors in chosen cell types. We demonstrate the power of this method in the cerebellum, where zolpidem rapidly induces significant motor deficits when Purkinje cells are made uniquely sensitive to its action. This combined molecular and pharmacological technique has demonstrable advantages over targeted cell ablation and will be invaluable for investigating many neuronal circuits.

Top
  1. Department of Clinical Neurobiology, University of Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.
  2. Institute of Biomedicine, Pharmacology, Biomedicum Helsinki, POB 63 (Haartmaninkatu 8), University of Helsinki, FI-00014 Helsinki, Finland.
  3. Department of Pharmacology, University College London, Gower Street, London WC1E 6BT, UK.
  4. MRC Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, UK.
  5. Center for Brain Research, Section of Biochemistry and Molecular Biology of the Nervous System, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria.
  6. Present address: Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
  7. These authors contributed equally to this work.

Correspondence to: Peer Wulff1,6,7 e-mail: p.wulff@abdn.ac.uk

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Presynaptic NMDA receptors get into the act

Nature Neuroscience News and Views (01 May 2004)

Bypassing interneurons: inhibition in neocortex

Nature Neuroscience News and Views (01 Jul 2007)

See all 4 matches for News And Views

Extra navigation

Subscribe to Nature Neuroscience

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT